News item covers ISMP’s alert regarding Paxlovid for treatment of COVID-19, highlighting that a dose reduction is necessary for patients with moderate renal impairment.
For the full text, visit APhA online.
More News
Revised Tool Can Help Healthcare Organizations Update Their Own “Do Not Use” Lists
Nonprofit patient safety organization releases annual list of 10 patient safety threats in conjunction with Patient Safety Awareness week, March 10 to 16
This article appeared on the MyChesCo website on February 26, 2024.